Cannabitriol (CBT) is a phytocannabinoid first isolated in 1966, an oxidation product of tetrahydrocannabinol (THC) which has been identified both as a trace component of cannabis and as a metabolite in cannabis users. Its pharmacology has been little studied, though it has been found to act as an antiestrogen and aromatase inhibitor.
See also 8,11-Dihydroxy-THC 9-OH-HHC Cannabicitran (CBTC) Cannabiripsol Delta-3-THC
References
External links